| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -74.1% |
| R&D Expense | $240.2M | +42.5% |
| SG&A Expense | $99.7M | +71.7% |
| Operating Income | -$338.9M | -52.2% |
| Pre-tax Income | -$298.4M | -39.1% |
| Income Tax | $0 | — |
| Net Income | -$298.4M | -39.1% |
| EPS (Basic) | -$3.69 | +0.0% |
| EPS (Diluted) | -$3.69 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $264.5M | +381.9% |
| Short-term Investments | $1.09B | +116.3% |
| Current Assets | $1.38B | +139.6% |
| Total Assets | $1.43B | +125.8% |
| Current Liabilities | $59.7M | +35.8% |
| Total Liabilities | $109.8M | +14.1% |
| Stockholders' Equity | $1.32B | +145.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$226.0M | -35.9% |
| Capital Expenditures | $3.8M | -18.0% |
| Investing Cash Flow | -$574.8M | -186.8% |
| Financing Cash Flow | $1.01B | +159.8% |
| Free Cash Flow | -$229.8M | -34.4% |
| +0.0% |